[LGND] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
29-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- 242.18%
YoY- 225.14%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 41,531 30,978 28,101 32,868 26,366 43,979 50,382 -12.09%
PBT -65,390 113,447 17,097 -15,344 3,171 55,536 24,140 -
Tax -13,479 27,308 -1,091 -2,552 881 11,922 38,674 -
NP -51,911 86,139 18,188 -12,792 2,290 41,949 -14,534 133.84%
Tax Rate - -24.07% 6.38% - -27.78% -21.47% -160.21% -
Total Cost 93,442 -55,161 9,913 45,660 24,076 2,030 64,916 27.51%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -124.99 278.07 64.72 -38.92 8.69 95.38 -28.85 165.99%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -2.88 4.86 1.04 -0.74 0.13 2.46 -0.86 124.00%
EPS Diluted -2.88 4.75 1.03 -0.74 0.13 2.33 -0.86 124.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.